These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37744571)

  • 41. Understanding and measuring symptoms and health status in asthma COPD overlap: content validity of the EXACT and SGRQ.
    Nelsen L; Gater A; Panter C; Tolley C; Lee L; Pascoe S
    J Patient Rep Outcomes; 2017; 2(1):18. PubMed ID: 29757333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional study.
    Iyer S; Roughley A; Rider A; Taylor-Stokes G
    Support Care Cancer; 2014 Jan; 22(1):181-7. PubMed ID: 24026981
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patient-reported outcomes from the randomized phase III ALEX study of alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer.
    Pérol M; Pavlakis N; Levchenko E; Platania M; Oliveira J; Novello S; Chiari R; Moran T; Mitry E; Nüesch E; Liu T; Balas B; Konopa K; Peters S
    Lung Cancer; 2019 Dec; 138():79-87. PubMed ID: 31654838
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Importance and relevance of pulmonary symptoms among patients receiving second- and third-line treatment for advanced non-small-cell lung cancer: support for the content validity of the 4-item Pulmonary Symptom Index.
    Magasi S; Mallick R; Kaiser K; Patel JD; Lad T; Johnson ML; Kaplan EH; Cella D
    Clin Lung Cancer; 2013 May; 14(3):245-53. PubMed ID: 23036663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient Experience of Lichen Planus: A Qualitative Exploration of Signs, Symptoms, and Health-Related Quality of Life Impacts.
    Mahon-Smith A; Clifford M; Batish A; Sharp R; Panter C; Naujoks C; Schruf E; Compagno N; Moreno SG
    Dermatol Ther (Heidelb); 2023 Sep; 13(9):2001-2017. PubMed ID: 37505393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Meaningful score changes for SF-36v2, FACIT-fatigue, and RASIQ in rheumatoid arthritis.
    Rendas-Baum R; Lin X; Kosinski M; Bjorner JB; Bracher MG; Chen WH
    J Patient Rep Outcomes; 2024 Jan; 8(1):9. PubMed ID: 38252223
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Qualitative exploration of the visual function impairments and impacts on vision-dependent activities of daily living in Retinitis Pigmentosa and Leber Congenital Amaurosis: content validation of the ViSIO-PRO and ViSIO-ObsRO measures.
    Kay C; Audo I; Naujoks C; Spera C; Fischer MD; Green J; Durham T; Williamson N; Bradley H; Barclay M; Sims J; Banhazi J; Patalano F
    J Patient Rep Outcomes; 2023 Jul; 7(1):74. PubMed ID: 37466759
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Symptoms, impacts, and suitability of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT™) questionnaire in patients with sarcoidosis-associated pulmonary hypertension (SAPH): a qualitative interview study.
    Currie BM; Davies EW; Beaudet A; Stassek L; Kleinman L; Baughman RP
    BMC Pulm Med; 2021 Nov; 21(1):365. PubMed ID: 34772372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Qualitative study to characterize patient experience and relevance of patient-reported outcome measures for patients with metastatic synovial sarcoma.
    Eliason L; Grant L; Francis A; Cardellino A; Culver K; Chawla SP; Arbuckle R; Pokras S
    J Patient Rep Outcomes; 2022 May; 6(1):43. PubMed ID: 35507231
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of the Patient- and Observer-Reported PRUCISION Instruments to Assess Pruritus and Sleep Disturbance in Pediatric Patients with Cholestatic Liver Diseases.
    Gwaltney C; Bean S; Venerus M; Karlsson L; Warholic N; Kjems L; Horn P
    Adv Ther; 2022 Nov; 39(11):5126-5143. PubMed ID: 36066744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Telephone interventions for symptom management in adults with cancer.
    Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Meaningful Within-Patient Change in Subjective Total Sleep Time in Patients with Insomnia Disorder: An Analysis of the Sleep Diary Questionnaire Using Data from Open-Label and Phase III Clinical Trials.
    Phillips-Beyer A; Kawata AK; Kleinman L; Seboek Kinter D; Flamion B
    Pharmaceut Med; 2024 Mar; 38(2):133-144. PubMed ID: 38302765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pulmonary hypertension due to interstitial lung disease or chronic obstructive pulmonary disease: a patient experience study of symptoms and their impact on quality of life.
    DuBrock HM; Nathan SD; Reeve BB; Kolaitis NA; Mathai SC; Classi PM; Nelsen AC; Olayinka-Amao B; Norcross LN; Martin SA
    Pulm Circ; 2021; 11(2):20458940211005641. PubMed ID: 33868642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Understanding Patient Experience in Biliary Tract Cancer: A Qualitative Patient Interview Study.
    Patel N; Lie X; Gwaltney C; Rokutanda N; Barzi A; Melisi D; Macarulla T; Ueno M; Kim ST; Meyers O; Workman C; Bachini M; Cohen G
    Oncol Ther; 2021 Dec; 9(2):557-573. PubMed ID: 34244955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and psychometric validation of the Nausea/Vomiting Symptom Assessment patient-reported outcome (PRO) instrument for adults with secondary hyperparathyroidism.
    McHorney CA; Bensink ME; Burke LB; Belozeroff V; Gwaltney C
    J Patient Rep Outcomes; 2017; 2(1):6. PubMed ID: 29757328
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation and Application of Thresholds to Define Meaningful Change in Vasomotor Symptoms Frequency: Analysis of Pooled SKYLIGHT 1 and 2 Data.
    Morga A; Zimmermann L; Valluri U; Siddiqui E; McLeod L; Bender RH
    Adv Ther; 2024 Jul; 41(7):2845-2858. PubMed ID: 38775925
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of Focal Segmental Glomerulosclerosis Patient-Reported Outcome Measures: Symptom Diary and Symptom Impact Questionnaire.
    Mathias SD; Vallow S; Gipson DS; Thorneloe KS; Sprecher D
    Am J Kidney Dis; 2017 Oct; 70(4):532-540. PubMed ID: 28663063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cancer Patients' Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life.
    Epstein RS; Basu Roy UK; Aapro M; Salimi T; Moran D; Krenitsky J; Leone-Perkins ML; Girman C; Schlusser C; Crawford J
    Patient Prefer Adherence; 2021; 15():453-465. PubMed ID: 33658769
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Meaningful Change Thresholds and Fatigue Severity Points on Patient-Reported Outcomes by the Fatigue Symptoms and Impacts Questionnaire in Patients With Relapsing Multiple Sclerosis.
    Hudgens S; Katz EG; Davies E; Keenan A; Sidorenko T; Jamieson C
    Value Health; 2024 May; 27(5):598-606. PubMed ID: 38401796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.